Recent HAE News
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 05/20/2026 10:31:33 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/19/2026 09:37:56 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/19/2026 09:36:33 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/19/2026 09:34:54 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/19/2026 09:33:01 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/19/2026 09:31:34 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/19/2026 09:29:48 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/19/2026 09:28:15 PM
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 05/13/2026 02:40:04 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/07/2026 10:02:40 AM
- Haemonetics Corporation Announces Fourth Quarter Fiscal 2026 Financial Results Available on Investor Relations Website • PR Newswire (US) • 05/07/2026 10:00:00 AM
- Haemonetics to Present at Bank of America 2026 Healthcare Conference • PR Newswire (US) • 05/05/2026 10:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/01/2026 08:18:06 PM
- New Study Highlights Safety and Efficacy Profile of Haemonetics' VASCADE MVP® XL in Large-Bore Venous Access Closure Procedures • PR Newswire (US) • 04/24/2026 10:20:00 AM
- Haemonetics Sets Date for Publishing Fourth Quarter and Fiscal Year 2026 Results: May 7, 2026 • PR Newswire (US) • 04/01/2026 08:05:00 PM
- Haemonetics Receives FDA Approval for Expanded Labeling of the VASCADE MVP® XL Venous Vascular Closure System • PR Newswire (US) • 03/30/2026 08:15:00 PM
- Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 03/03/2026 11:24:41 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/03/2026 11:09:10 AM
- Haemonetics Receives FDA Clearance for NexSys® PCS Plasma Collection System with Persona® PLUS Technology • PR Newswire (US) • 02/23/2026 09:15:00 PM
- Haemonetics to Present at Raymond James 47th Annual Institutional Investors Conference • PR Newswire (US) • 02/20/2026 09:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/12/2026 09:15:21 PM
- Haemonetics Tops Q3 Forecasts and Raises Fiscal 2026 Outlook • IH Market News • 02/05/2026 01:30:59 PM
